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Abstract
Background: This trial evaluates interventions that utilize data entered at point-of-care in the Palestinian maternal
and child eRegistry to generate Quality Improvement Dashboards (QID) for healthcare providers and Targeted
Client Communication (TCC) via short message service (SMS) to clients. The aim is to assess the effectiveness of the
automated communication strategies from the eRegistry on improving attendance and quality of care for pregnant
women.
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Methods: This four-arm cluster randomized controlled trial will be conducted in the West Bank and the Gaza Strip,
Palestine, and includes 138 clusters (primary healthcare clinics) enrolling from 45 to 3000 pregnancies per year. The
intervention tools are the QID and the TCC via SMS, automated from the eRegistry built on the District Health
Information Software 2 (DHIS2) Tracker. The primary outcomes are appropriate screening and management of
anemia, hypertension, and diabetes during pregnancy and timely attendance to antenatal care. Primary analysis, at
the individual level taking the design effect of the clustering into account, will be done as intention-to-treat.
Discussion: This trial, embedded in the implementation of the eRegistry in Palestine, will inform the use of digital
health interventions as a health systems strengthening approach.
Trial registration: ISRCTN Registry, ISRCTN10520687. Registered on 18 October 2018
Keywords: Attendance, DHIS2, Quality of care, Antenatal care, Maternal and newborn health, eHealth, Digital
health, Electronic registry, eRegistries, Health systems, SMS, Audit and feedback, Effective coverage, Targeted Client
Communication, Palestine
Background
Scale up of effective, high-quality interventions is essen-
tial in order to reach the Sustainable Development Goals
and achieve Universal Health Coverage in maternal and
child healthcare [1, 2]. Antenatal care (ANC), postpar-
tum care (PPC), and newborn care in low- and middle-
income countries show low effective coverage [3, 4].
Countries can improve healthcare systems by exploit-
ing the potential of digital technology. Digital health in-
formation systems with individual-level data and mobile
technologies are expanding globally and provide an op-
portunity to support, involve, and influence healthcare
providers and their clients’ behavior [5–7]. However, ef-
fective digital health interventions are complex and re-
quire careful design, implementation, and evaluation [8].
Audit and feedback, widely used quality improvement
interventions, allow healthcare providers to assess and
adjust their performance and, as a result, improve the
quality of the care they deliver [9, 10]. Audit and feed-
back can be defined as any summary of clinical perform-
ance of healthcare over a specified period of time and
may include recommendations for clinical actions [11].
It is most effective when it is presented more than once,
given both verbally and in writing, provided by a super-
visor or respected colleague, presented with clear goals
and action plans, aimed to decrease targeted behavior,
directed towards the recipient with room for improve-
ment, and to health professionals typically working with
guideline-bound clinical activities [12]. The model of ac-
tionable feedback emphasizes that feedback should be
timely, individualized, non-punitive, and meaningful to
the recipient to be effective [13]. Explicit use of theory
to inform intervention development, and user involve-
ment in all stages of a digital health intervention devel-
opment, implementation, and evaluation, is
recommended, but seldom described [14–17].
Digital Targeted Client Communication (TCC) can
utilize data, such as demographic characteristics and
health status, to tailor communications to an individual’s
specific needs if good-quality individual-level data are
available [18, 19]. Short message service (text message
(SMS)) is often used as a medium to deliver TCC inter-
ventions. Appointment reminders alone, or coupled with
generic health promotion messages, can impact people’s
knowledge, health literacy, and attitudes and thus im-
prove healthy behavior and utilization of healthcare ser-
vices [17, 20–23]. However, even though tailored, co-
designed, theory-driven TCC interventions tend to be
more effective than generic messages, evidence is
needed, especially in the field of maternal and child
health (MCH) in low- and middle-income countries [15,
19, 21, 22].
Palestinian context
The total population in Palestine is 4.17 million, 2.58
million (62%) in the West Bank and 1.59 million (38%)
in the Gaza Strip [24]. There are approximately 62,000
live births in the West Bank and 56,000 live births in the
Gaza Strip annually. Individuals under 18 years of age
constitute 48% of the total population, and the fertility
rate is 3.8 in the West Bank and 4.9 in the Gaza Strip.
MCH is an important area in the Palestinian health-
care system, and gestational anemia, hypertensive disor-
ders of pregnancy, gestational diabetes mellitus, and fetal
growth restriction are identified as priority conditions
for prevention [25]. Approximately 43% of pregnant
women attend public ANC services, but only 13% ac-
cording to the recommended national schedule, which
results in low effective coverage [26]. Both the utilization
and quality of health services have room for improve-
ment. MCH supervisors, each responsible for 16 to 54
public primary healthcare clinics (PHCs), supervise mid-
wives, nurses, and community health workers, mainly by
checking registers and clinical equipment [27].
The routine governmental documentation tool for
ANC and PPC in Palestine is the eRegistry built on the
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District Health Information Software 2 (DHIS2)
Tracker [28]. The eRegistry is a web-based open-
source information system for the longitudinal collec-
tion, storage, retrieval, analysis, and dissemination of
information on health determinants and outcomes for
individual persons [5, 29]. The implementation of the
Palestinian eRegistry was carried out by the Ministry
of Health (MoH) and the Palestinian National Insti-
tute of Public Health (PNIPH), with support from the
Norwegian Institute of Public Health and the Univer-
sity of Oslo, as a measure to support healthcare pro-
viders in screening and management, and improve
monitoring and evaluation [30, 31].
The eRegistry in Palestine provides clinical decision
support based on national guidelines, including refer-
ral recommendations. It creates longitudinal preg-
nancy records and removes the need for secondary
data reporting or manual aggregation for reporting.
The eRegistry’s comprehensive information gathered
in a continuous fashion allows TCC via SMS to cli-
ents and QID for healthcare providers, but the effect-
iveness is unknown.
Objectives
The primary objectives of the eRegCom cluster ran-
domized controlled trial (CRCT) are, compared to the
basic eRegistry functionalities in public MCH PHCs
in Palestine, to estimate the effectiveness of the
eRegistry’s:
 Quality Improvement Dashboard (QID) on
improving appropriate screening and management
for anemia, hypertension, and diabetes during
pregnancy by the healthcare provider
 Targeted Client Communication (TCC) on
improving timely attendance to ANC by the woman
 QiD and TCC interventions combined on the
measures described above
We will also estimate the effectiveness across equity
measures and, in a sub-sample, assess the effect of
the TCC intervention on pregnant women’s worries
and perceptions of ANC, including the quality of care
and information received from the health system
(Fig. 1).
Fig. 1. The effect of the TCC intervention on pregnant women’s worries in a sub-sample
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Methods
Trial design
This CRCT is a superiority trial with four parallel arms
(TCC, QID, TCC and QID, and control). The unit of
randomization is an individual PHC, with the exception
of two clusters. These two clusters include two PHCs
each, where the pair of PHCs is served by the same
healthcare provider.
Study setting
The most common organizational structure in the public
maternal and child healthcare system in Palestine in-
cludes two healthcare providers per clinic, mainly mid-
wives, nurses, and/or community health workers, in
addition to a doctor serving several clinics. Each user in
the governmental eRegistry has a unique username and
password, which enable access to records and specific
system features according to their assigned role. The
woman’s personal ID number is used to create an elec-
tronic ANC record for her pregnancy. The sociodemo-
graphic, obstetric, and medical information including
clinical tests, laboratory, and ultrasound measurement
results are entered into the eRegistry at point-of-care.
The data trigger different digital health interventions
such as the guideline-based clinical decision support and
automated public health reports. Women identified with
certain risk factors are referred for additional manage-
ment, and their records are available in the so-called
high-risk clinics after referral [31].
Eligibility criteria
All public PHCs offering ANC and PPC services using
the eRegistry were eligible for the study. PHCs that
enrolled less than 45 or more than 3000 new pregnan-
cies in 2016 were excluded. No exclusion criteria were
made based on individual healthcare provider’s or preg-
nant women’s characteristics (Fig. 2).
A total of 138 clusters (individual PHC and a combin-
ation of two PHCs served by the same healthcare pro-
vider for two clusters) were eligible for randomization.
They enrolled a mean of 344 and a median of 131 new
pregnant women in 2016 (Additional file 1). Data from
all ANC visits occurring in the included PHCs during
the study period will be used to assess our outcomes.
Intervention
The interventions are at the cluster-level targeting
nurses, midwives, and community health workers, re-
ferred to as healthcare providers, and their clients.
The Quality Improvement Dashboard intervention
The QID intervention is the provision of access to the
QID within their routine eRegistry, as well as training of
healthcare providers on how to use it.
As part of the QID intervention development process,
public healthcare providers, supervisors, and health sys-
tem administrators were interviewed to map the existing
supervision and feedback system [27]. We found that
healthcare providers received irregular supervision visits
with limited focus on performance improvement at the
clinical level. Findings and recommendations regarding
benchmarking [32], the use of SMART (Specific, Meas-
urable, Achievable, Relevant and Timely) criteria, con-
cepts from social nudging and Enhanced active choice
[33], and the Model of Actionable Feedback [13] in-
formed the design of the QID. eRegistry users’, nursing
Fig. 2 Flow diagram showing eligible primary healthcare clinics (PHCs) and allocation
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and medical directors’, and PNIPH and MoH staff’s re-
views informed the revisions. The final version was
translated into the local Arabic language.
The training curriculum is founded on quality im-
provement theories and models such as the Plan, Do,
Study, Act (PDSA) cycles [34]. Healthcare providers
learn how they can use the QID, which presents indica-
tors of quality gaps in their clinic, as a tool to improve
the quality of the care they provide.
The QID includes four tabs for each focus area,
namely anemia, hypertension, diabetes, and attendance.
Healthcare providers are given a new focus area every
week through a message in the eRegistry that congratu-
lates a good performing PHC or presents an evidence-
based statement on the week’s focus area. Each tab con-
tains performance indicators calculated from data en-
tered at point-of-care. The indicators are presented as
an average over the last 3 months, in both tables and
graphs, and benchmarked with clinics within the district.
The clinic’s performance level—defined as an index of
the absolute and relative values of an overall screening
and an overall management indicator—drives the appro-
priate action items for each focus area. Two screening
and two management action items that include recom-
mendations for improvement are presented in colors
(green = good performance, yellow = room for improve-
ment, red = large room for improvement) with monthly
updates (Fig. 3). The healthcare providers can score the
action items via a thumbs up/down icon and add written
comments.
The Targeted Client Communication intervention
The TCC intervention is automated text messages sent
via SMS from the eRegistry to pregnant women, and
training of healthcare providers on how to enroll women
in the program.
The TCC intervention development process, including
the full-text message library, is described in detail else-
where [35]. In short, pregnant women and healthcare
providers were interviewed to identify how pregnant
women perceive their risks of getting anemia, hyperten-
sion, and diabetes during pregnancy and susceptibility to
fetal growth restriction, in addition to benefits and bar-
riers of attending ANC, using the Health Belief Model.
The findings, concepts from social nudging and En-
hanced active choice [33], and the Model of Actionable
Feedback [13] informed the content, medium, timing,
and frequency of the TCC intervention.
The training includes how to register and withdraw
women, and the timing and the content of the text mes-
sages. Healthcare providers register women that agree to
receive text messages by ticking a box in the eRegistry.
This can be done at any time in gestation, preferably at
the first visit.
The tailored text messages include the woman’s name
and her clinic’s name and may also include the date of
her next appointment (Table 1). Those that include in-
formation about one or more of the high priority areas
(anemia, hypertension, and diabetes during pregnancy,
and fetal growth restriction) will be sent at the time
these conditions are screened for, namely at the 16, 18–
22, 24–28, 32, or 36 weeks’ gestation routine ANC visit.
However, women with documented anemia, hyperten-
sion, diabetes, or fetal growth restriction will not receive
the information about routine screening for that condi-
tion, e.g., women with diabetes will not receive a text
message about the routine screening for diabetes at 24–
28 weeks’ gestation. The text messages will be sent to
the mobile number registered on the woman after work-
ing hours during ANC at the following time points:
 At registration, a welcome message including
information about how to un-enroll
 One week prior to a timely scheduled routine visit
 Three days prior to a timely scheduled routine visit
to women with risk factors for anemia,
hypertension, diabetes, or fetal growth restriction
 Twenty-four hours prior to a visit
 Twenty-four hours after a missed timely scheduled
routine visit
 Recapture message 24 h prior to the start of the
appropriate time window for a routine visit to
women without any timely scheduled routine visit in
the future
Adherence, training, and concomitant care
The TCC and QID interventions in the eRegistry are
available to healthcare providers working in PHCs ran-
domized to trial arms receiving one or both of the digital
health interventions. The research team trained the
trainers, who were eRegistry staff at PNIPH and nursing
directors, each representing a governorate. Healthcare
providers from TCC and QID intervention PHCs were
trained separately, and healthcare providers working in
PHCs randomized to both interventions received both
trainings. The trainings were conducted in the first quar-
ter of 2019, and each session lasted for half a day. A
follow-up training session was conducted in September
2019. Healthcare providers in QID intervention PHCs
received a video presenting new functionalities in the
QID at the start of the trial. New employees in interven-
tion PHCs will receive on-site training from one of the
trainers.
MCH supervisors will carry out similar periodic super-
vision visits to all PHCs in all arms of this CRCT.
Women will not receive any concomitant care across
intervention and control PHCs.
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Outcomes
The outcomes represent key areas of quality concerns in
Palestine and are in line with our previous eRegQual
CRCT, a study assessing the effect of using an eRegistry
versus paper-based ANC records [25]. The Palestinian
ANC guidelines for the recommended gestational week
(Table 2) for screening and management of anemia,
hypertension, and diabetes have defined our outcomes.
For routine visits recommended for one specific week,
we have made the time window for the outcome mea-
sures 2 weeks wider than the guideline, to allow some
flexibility for maternal choice and time for e.g. labora-
tory results to be received and documented in the
eRegistry.
Primary outcomes
Comparison I: QID arm vs control arm The primary
outcome in comparison 1 is the proportion of women
who receive appropriate screening and management of
anemia, hypertension, and diabetes (Tables 3, 4, 5, 6,
and 7). For example for anemia, the proportion is calcu-
lated by identifying the number of ANC visits where
anemia should have been screened for and/or managed
(denominator), and among them where anemia was ap-
propriately screened for and/or managed (numerator).
Only the first step in the management algorithm will be
included (Tables 3, 4, 5, 6, and 7). Pregnant women with
documented ongoing anemia, hypertension, or diabetes
Fig. 3 Quality Improvement Dashboard for anemia to healthcare providers from the eRegistry. Top left: individualized on clinic level; top right:
reminders of the week’s focus area, namely anemia, hypertension, diabetes, or attendance; tables: indicators with benchmarks; graphs: percentage
average over the last 3 months; right: action items presented in colors (green = good performance, yellow = room for improvement, red = large
room for improvement)
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prior to the timely routine visit will not be included in
the denominator for appropriate screening and manage-
ment of anemia, hypertension, and diabetes respectively.
Comparison II: TCC arm vs control arm The primary
outcome in comparison 2 is the proportion of all timely
routine ANC visits that a woman was eligible for, where
the woman attended (Table 2). The first ANC booking
visit is excluded, and each timely routine visit will be
counted separately as a singular opportunity to succeed
or fail in attendance.
Comparison III: QID + TCC arm vs control arm The
primary outcome in comparison 3 is the product of the
quality of care (comparison 1) and the utilization of care
(comparison 2) to assess the effective coverage. For ex-
ample for anemia, it is the proportion of all timely rou-
tine ANC visits where anemia should have been
screened for and/or managed, where the woman
attended and anemia was appropriately screened for
and/or managed.
Effect on healthcare equity We will assess the effects
of the interventions on the primary outcomes across
equity measures used in routine statistics in Palestine.
The data points include average monthly household in-
comes (less than 200; 200–900; 901–1824; 1825–3054;
and > 3055 Israeli new Shekel), mother’s years of educa-
tion (< 10; 10–13 years; > 13 years), age at marriage (less
than 20; 21–25; 26–30; 31–35; 36–40; greater than 40
years), and age at first pregnancy (less than 20; 20–25;
26–30; 31–35; 36–40; greater than 40 years).
Other outcomes We will assess the proportion of
women receiving appropriate screening and appropriate
management separately at each visit for anemia, hyper-
tension, and diabetes. We will also measure the reten-
tion rate from ANC to PPC and timely screening and
management of fetal growth. The data entry in the eReg-
istry is continuous and the randomization permanent,
which enable the analysis of overall health outcomes in a
continuous and longitudinal manner for each individual
woman. We might assess other outcomes if the interven-
tion(s) shows an effect.
Timeline
Care providers in PHCs randomized to the TCC inter-
vention have had the opportunity to register pregnant
Table 1 Example text messages send to an overweight pregnant woman without identified anemia, diabetes, or hypertension
Welcome One week prior to a
visit






after a missed visit
Twenty-four hours
prior to a missing visit
Dear Abi,
Most women attend
antenatal care for their
own and baby’s health.
The healthcare provider
will measure your blood
pressure, hemoglobin
and blood glucose level.
You will receive text
message appointment
reminders. Please let us




The date of your
upcoming appointment
is 2020.04.20. One in 20
develop high blood
pressure in pregnancy,
and this may affect your
health and the growth




amount of protein in
urine as they may be a
sign of high blood
pressure. Tamoon clinic
Dear Abi,
2020.04.20 is your next
appointment, as agreed.
High body weight before
pregnancy, may increase
the risk of developing
high blood pressure. The
healthcare provider will
measure your blood
pressure and the amount













Sorry to have missed
you at yesterday’s
appointment. We hope
to see you back with us






which is coming up
soon. Timely attendance
to every antenatal care





contact us to schedule
your next visit. We are
ready to provide you
with care, and hope to
see you soon. Tamoon
clinic
Table 2 Time windows for the outcome measures and routine ANC visits including the primary screening test
First visit Routine visits
Recommended
occurrence of ANC visits,
GW
Any week 16 18–22 24–28 32 36
Included in outcome
measures, GW


















ANC antenatal care, GW weeks of gestation
aAnemia, hypertension, diabetes, and fetal growth restriction according to the Palestinian guidelines
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women to the text message service since June 2019. Care
providers in PHC randomized to the QID intervention
received access to the QID December 2019. We expect
to reach the target sample size after approximately 6
months (Fig. 4).
Sample size
Sample size calculations for the primary outcomes were
performed in STATA “clustersampsi” (StataCorp. 2015.
Stata Statistical Software: Release 14. College Station,
TX: StataCorp LP). We estimated the minimum detect-
able difference for comparison of each intervention arm
with the control arm without assuming the effect of
multiple comparison (using a single control to each
intervention arm). The control prevalence for the pri-
mary outcome, using data from the eRegQual CRCT,
ranged from 30 to 85% for comparison I (QID vs con-
trol) and from 34 to 53% for comparison II (TCC vs
control) (unpublished results). The 138 eligible clusters
have an average of 172 new pregnancies per 6 months
(ranging from 23 to 1500) and a 1.69 coefficient of vari-
ation of cluster size (2016 data). We assumed a priori
intra-cluster correlation coefficient (ICC) of 0.05 and set
the statistical significance level to 5%. We are 80% pow-
ered to detect an estimated relative 50% increase for the
outcomes with the smallest control prevalence (e.g., im-
proving anemia screening and management at 24–28
weeks’ gestation from 30 to 45%).
Recruitment
PHCs that fulfilled the recruitment criteria were ran-
domized to one of the four arms. Healthcare providers
working in PHCs randomized to one or both of the in-
terventions received training as described (the “Interven-
tion” section).
No financial or non-financial incentives are or will be
provided to the woman, public health officers, or health-
care providers at the PHCs included in the trial.
Allocation
Statisticians at the Center for Intervention Science in
Maternal and Child Health (CISMAC), University of
Bergen, Norway, performed the randomization inde-
pendently without any influence from the research team.
PHCs were allocated to the TCC intervention, QID
intervention, TCC and QID intervention, or control
group with an equally 1:1:1:1 randomization ratio. The
randomization was stratified by the point in time the
eRegistry was implemented, and constrained on labora-
tory availability, ultrasound availability, and the size of
the PHC.
In total, 10,000 randomization allocations were gener-
ated. The 10% best and balanced allocations with the
least differences between the arms for the given covari-
ates were identified, and one of these allocations were
randomly selected for the trial [36].
Blinding
Healthcare providers and women attending care at PHCs
included in the trial are blinded to the outcome mea-
sures. Women are expected to be blinded to the alloca-
tion of the QID intervention, but not to the TCC
intervention due to the nature of the intervention.
Healthcare providers are not blinded to the allocation of
any intervention.
Data will be extracted from the eRegistry and trans-
formed to anonymous datasets by blinded data analysts
at PNIPH. Allocation codes will be generated for each
primary outcome separately (e.g., A, B, C, and D; E, F, G,
and H; I, J, K, L, and M). Our independent trial monitors
(CISMAC) will keep the codes, which will be provided
as allocation groups (intervention TCC, intervention
Table 3 Anemia screening test, result, and appropriate
management
Hemoglobin test at first visit, 24–28, and 36 weeks’ gestation
Hb≥ 11 g/dL Hb 10.9–7 g/dL Hb < 7g/dL
No further action Hb after 1 month Refer to hospital
Table 4 Hypertension screening test, result, and appropriate
management prior to 20 weeks’ gestation
Blood pressure prior to 20 weeks’ gestation, test at the first visit
and at 16, 18–22 weeks’ gestation
SBP < 140 mmHg and DBP <
90 mmHg
SBP≥ 140 mmHg, DBP≥
90 mmHg
No further action Refer to high-risk clinic
SBP systolic blood pressure, DBP diastolic blood pressure
Table 5 Hypertension screening test, result, and appropriate
management at or after 20 weeks’ gestation
Blood pressure at or after 20 weeks’ gestation, test at 18–22, 24–
28, and 36 weeks’ gestation
SBP < 140 mmHg and
DBP < 90 mmHg
DBP 90–99 mmHg, SBP
140–149 mmHg
DBP ≥ 100 mmHg,
SBP≥ 150 mmHg
No further action New BP within 4 days Refer to hospital
SBP systolic blood pressure, DBP diastolic blood pressure
Table 6 Diabetes screening test, result, and appropriate
management prior to 24 weeks’ gestation
Urine glucose test at booking prior to 24 weeks’ gestation
Negative Positive
No further action Blood glucose test
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QID, intervention TCC and QID vs control) for each set
of outcomes after the completion of analyses.
Data extraction methods
Healthcare providers will routinely and continuously
enter data in the eRegistry during patient care, and all
outcomes are informed by secondary data. Anonymous
data will be extracted from the eRegistry in accordance
with the standard operating procedure (SOP) of the Pal-
estinian maternal and child health eRegistry for routine
registry operations and use of data for research
purposes.
Data management
The data in the eRegistry will be managed in accordance
with the governance structure approved by the Palestin-
ian MoH. Only pre-defined anonymous data needed for
the outcomes will be extracted from the eRegistry by
PNIPH staff for this trial. The pre-defined anonymous
original dataset will be provided to the trial sponsors
and to our independent trial monitors (CISMAC), for in-
dependent monitoring and safeguarding.
Statistical methods
Intention-to-treat analysis will be performed for the pri-
mary outcomes to compare each independent interven-
tion arms (QID, TCC, and QID and TCC) with the
control, using individual-level data taking the design ef-
fect of the clustering into account. Descriptive statistics
will be reported, and appropriate tests will be used to
compare variables between the groups. Statistical signifi-
cance will be set at p < 0.05. Appropriate bivariate and
multivariate regression analyses will be performed. The
regression analyses will take the design effect of the clus-
tering into account and enable adjustment for any rele-
vant variables not accounted for during randomization.
We will do complete case analyses and consider appro-
priate imputations for missing data. We will present
cluster-wise effects of the intervention to explore
whether a disproportionately large part of the effect can
be ascribed to extreme effects in a few large clusters.
The interaction effect of the two interventions will be
performed as a secondary analysis. We will conduct per-
protocol analyses in cases of protocol violations, includ-
ing withdrawal of the eRegistry, and data from these
clusters will be excluded from the time of violation when
appropriate. Data will be analyzed using the latest ver-
sion of STATA (Stata Statistical Software: College Sta-
tion, TX: StataCorp LP).
Table 7 Diabetes screening test, result, and appropriate
management at or after 24 weeks’ gestation
Blood glucose test at 24–28 weeks’ gestation
RBG < 105 mg/dL,





No further action New blood test within
3 weeks
Refer to a diabetes
clinic
RBG random blood glucose, FBG fasting blood glucose
Fig. 4 Schedule of enrolment, interventions, and assessments (SPIRIT figure)
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Data monitoring
Data management and monitoring will be done in ac-
cordance with the SOP of the Palestinian maternal and
child health eRegistry for routine registry operations.
We have not designated a Data and Safety Monitoring
Committee, due to the lack of potential significant harm,
nor an Endpoint Adjudication Committee, since we will
not use any subjective clinical data for outcome
measures.
Harms
This CRCT only utilizes the moment of opportunity of
an ongoing implementation to study new digital inter-
ventions in a health systems approach. No potential for
clinically significant harm has been identified during the
development and implementation of this trial. Potential
discomfort from worries may occur among women at-
tending ANC in clusters receiving the TCC intervention,
and this will be examined in a sub-sample (Fig. 1).
Confidentiality
Data confidentiality will be handled in accordance with
the Palestinian MoH’s legal framework for maternal and
child health electronic registries. This CRCT will only
utilize anonymous data to enable the assessment of the
effectiveness of the interventions. We will publish only
aggregate data, and no data on individual clients, care
providers, or identifiable clusters will be published.
Access to data
The data in the eRegistry belong to the Palestinian
MoH, and the researchers will not have access to the en-
tire registry or identifiable data of any kind. We will not
publish the full data set as our legal rights to the data is
limited to this analysis, and the richness of data would
allow for several other analyses for which there is no
ethics approval or approval from the Palestinian MoH.
We will, however, publish syntaxes needed to recreate
the data set from the eRegistry.
Dissemination plan
This protocol follows the Standard Protocol Items: Rec-
ommendations for Intervention trials (SPIRIT) guide-
lines. A formal revision of the protocol will be done if
the change can affect the study’s nature. The sponsors
and our independent trial monitors (CISMAC) will have
to agree on the revision, which will require renewed ap-
provals from both the ethic committee in Norway and in
Palestine, and the Palestinian health authorities. We will
inform all users and stakeholders and publish the results
of the CRCT in peer-reviewed open-access journals ac-
cording to the Consolidating Standards of Reporting Tri-
als (CONSORT) guidelines and the mHealth Evidence
Reporting and Assessment (mERA) checklist. Results
will also be presented at scientific meetings and con-
gresses and to the Palestinian MoH directly. With per-
mission from the MoH, we will inform all participating
PHC and their staff directly. We will acknowledge any
change in the study outcomes, study design, sample
sizes, or significant administrative aspects that will im-
pact the study’s nature when disseminating the findings.
Authorship will be in line with the recommendations of
the International Committee of Medical Journal Editors.
Summaries of the results and other relevant information
will be published on the eRegistries website.
Discussion
We have designed a multi-arm CRCT with two digital
health interventions, namely the QID for healthcare pro-
viders and TCC sent via SMS to pregnant women. The
eRegistry employs the collection and use of systematic,
uniform, and longitudinally entered routine clinical data,
in algorithms that instantly drive these digital health in-
terventions [5]. The QID and TCC interventions’ can
impact the quality of the ANC service and the utilization
of care by the pregnant woman, and the eRegCom
CRCT aims to estimate the effectiveness.
Routine data from the eRegistry in Palestine demon-
strates that both quality of care and utilization of care
have significant room for improvement, and both need
to be addressed to achieve a high effective coverage. To
ensure healthy lives and promote well-being for all at all
ages (Sustainable Development Goal 3), data and digital
health are highlighted as accelerators [37]. Our interven-
tions directly address the traditional lack of available
clinical data in a timely manner from routine health in-
formation system to healthcare providers and clients in
low- and middle-income countries [38], and the trial is a
direct response to the WHO review group on digital
health interventions’ request for effectiveness studies
[19].
We used the Principles for Digital Development [39]
and a human-centered design approach [40] to develop
the eRegistry, and also the QID and TCC interventions.
The Palestinian MoH and PNIPH have been heavily in-
volved in all stages of the CRCT and led the communi-
cation towards healthcare providers. We will, in
addition, assess the effect of the TCC intervention on
women’s worries in pregnancy and their perceptions of
ANC, to ensure that we do not introduce harm. Also,
the unintentional exacerbation of inequities based on
owning versus having access to a mobile phone will be
explored. We do not have data to explore inequities to-
wards those that do not own or have access to a mobile
phone, but acknowledge this issue.
Our experience from the pilot data collection and a re-
cent time-motion study [41] is that women are willing to
participate, and we expect a high response rate in the
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assessment of women’s worries and perception of ANC.
We anticipate to follow a comprehensive sample of
women throughout ANC due to Palestinian’s restrictions
on movement. Our large sample of PHCs, with no
individual-level eligibility criteria, is representative for
Palestine and presumably also for other settings with a
similar organizational structure.
One or two healthcare providers per PHC is the most
common organizational structure in Palestine, but some
healthcare providers may work or be relievers in more
than one clinic. Healthcare providers working in both
TCC intervention and control PHCs will receive the
TCC training, but they can only register women to re-
ceive text messages from the TCC intervention PHC.
Healthcare providers working in both QID intervention
and control PHCs will not receive the QID training, and
therefore not the full intervention. This is to avoid con-
tamination, as the action needed to improve care can be
done from any PHC without the QID tool itself. Even
though very few PHCs in the trial are operated by the
same healthcare provider, this may potentially lead to an
underestimation of the effectiveness.
Other limitations of this trial include the cadres of
healthcare professions we target, which is only nurses,
midwives, and community health workers. We exclude
doctors, due to the risk of contamination as they work
in several PHCs. However, we acknowledge that doc-
tors play a significant role in the care for pregnant
women. Our outcomes are dependent on the complete-
ness of documentation by the healthcare provider, as
our data source, the eRegistry, is the routine govern-
mental documentation tool with few required data
points. In order for the clusters to have comparable op-
portunities to succeed or fail, when it comes to man-
agement, we only include the first step in the
management algorithm for our primary outcomes. For
example, women with mild and moderate anemia, a
new hemoglobin result after 4 weeks, will be counted as
a success, without taking into account the response to
that result. However, we will assess the total manage-
ment chain in the secondary analysis.
We work closely with the Palestinian MoH to miti-
gate the risk of changes to the PHCs’ activities and staff
during the trial. A key aspect of the work with eRegis-
tries is to facilitate the uptake of the evidence-based
findings in other countries and promote our digital in-
terventions as “Global Public Goods” [29]. The eRegis-
try does involve high start-up costs, but once
implemented, the intervention only requires moderate
additional investments. We are in the midst of a digital
revolution, and more than 68 countries are using
DHIS2 [28], the eRegistry’s platform. The added value
of the digital interventions can add value to invest-
ments in eRegistries.
Trial status
The CRCT began recruiting on 1 December 2019, and
we expect to reach the target sample size after 6 months,
approximately 1 June 2020. Protocol version 2—April
2020.
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